ESC Premium Access

PSCK9 inhibition: a new horizon in LDL-C management

Event: ESC CONGRESS 2017
Topic: Lipids
Session type: Satellite Symposium - Experts on the Spot
Sponsored by Sanofi and Regeneron
Date: 28 August 2017
Time: 15:45 - 16:15

Congress Session

3 presentations in this session

Introduction - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor A. Catapano (Milan, IT)
Speaker: Doctor J. Robinson (Iowa, US)
Speaker: Professor C. Cannon (Boston, US)
Thumbnail

Identifying appropriate patients to treat: clinical cases and evidence discussion.

Speaker: Doctor J. Robinson (Iowa, US)
Thumbnail

Panel discussion - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor C. Cannon (Boston, US)
Speaker: Professor A. Catapano (Milan, IT)
Speaker: Doctor J. Robinson (Iowa, US)
Thumbnail

7 speakers from this session

Professor Alberico Catapano

University of Milan and IRCCS Multimedica, Milan (Italy)
38 presentations
3 followers

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Alberico Catapano

University of Milan and IRCCS Multimedica, Milan (Italy)
38 presentations
3 followers

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

This platform is supported by

logo Novo Nordisk